1 0 1 0 1 B-clinical_variable
month 2 7 2 7 I-clinical_variable
to 8 10 8 10 O
< 11 12 11 12 O
6 13 14 13 14 B-clinical_variable
months 15 21 15 21 I-clinical_variable
0.4 22 25 22 25 I-upper_bound
0.4 26 29 26 29 I-upper_bound
6 30 31 30 31 O
months 32 38 32 38 O
to 39 41 39 41 O
< 42 43 42 43 O
1 44 45 44 45 B-upper_bound
year 46 50 46 50 I-upper_bound
0.5 51 54 51 54 I-upper_bound
0.5 55 58 55 58 I-upper_bound

Contraception 0 13 59 72 B-contraception_consent

Contraception 0 13 73 86 O
must 14 18 87 91 O
continue 19 27 92 100 O
for 28 31 101 104 O
the 32 35 105 108 O
duration 36 44 109 117 O
of 45 47 118 120 O
study 48 53 121 126 O
treatment 54 63 127 136 O
and 64 67 137 140 O
for 68 71 141 144 O
at 72 74 145 147 O
least 75 80 148 153 O
seven 81 86 154 159 B-lower_bound
( 87 88 160 161 I-lower_bound
7 88 89 161 162 I-lower_bound
) 89 90 162 163 I-lower_bound
months 91 97 164 170 I-lower_bound
after 98 103 171 176 O
the 104 107 177 180 O
last 108 112 181 185 O
dose 113 117 186 190 O
of 118 120 191 193 O
study 121 126 194 199 O
treatment 127 136 200 209 O

Corticosteroids 0 15 210 225 B-treatment
: 15 16 225 226 O
Patients 17 25 227 235 O
receiving 26 35 236 245 O
systemic 36 44 246 254 B-treatment
corticosteroids 45 60 255 270 I-treatment

Creatinine 0 10 271 281 B-clinical_variable
clearance 11 20 282 291 I-clinical_variable
or 21 23 292 294 O
radioisotope 24 36 295 307 B-clinical_variable
glomerular 37 47 308 318 I-clinical_variable
filtration 48 58 319 329 I-clinical_variable
rate 59 63 330 334 I-clinical_variable
( 64 65 335 336 I-clinical_variable
GFR 65 68 336 339 I-clinical_variable
) 68 69 339 340 I-clinical_variable
≥70ml 70 75 341 346 O
/ 75 76 346 347 I-lower_bound
min/1.73 76 84 347 355 I-lower_bound
m2 85 87 356 358 I-lower_bound
or 88 90 359 361 I-lower_bound
2 91 92 362 363 I-lower_bound
) 92 93 363 364 O

Eastern 0 7 365 372 B-clinical_variable
Cooperative 8 19 373 384 I-clinical_variable
Oncology 20 28 385 393 I-clinical_variable
Group 29 34 394 399 I-clinical_variable
( 35 36 400 401 I-clinical_variable
ECOG 36 40 401 405 I-clinical_variable
) 40 41 405 406 I-clinical_variable
performance 42 53 407 418 I-clinical_variable
status 54 60 419 425 I-clinical_variable
scores 61 67 426 432 I-clinical_variable
of 68 70 433 435 O
0 71 72 436 437 B-lower_bound
, 72 73 437 438 O
1 74 75 439 440 O
, 75 76 440 441 O
or 77 79 442 444 O
2 80 81 445 446 B-upper_bound

Karnofsky 0 9 447 456 B-clinical_variable
score 10 15 457 462 I-clinical_variable
of 16 18 463 465 O
≥ 19 20 466 467 O
50 21 23 468 470 B-lower_bound
for 24 27 471 474 O
patients 28 36 475 483 O
> 37 38 484 485 O
16 39 41 486 488 B-lower_bound
years 42 47 489 494 I-lower_bound
of 48 50 495 497 O
age 51 54 498 501 B-age

Maximum 0 7 502 509 O
Serum 8 13 510 515 B-clinical_variable
Creatinine 14 24 516 526 I-clinical_variable
( 25 26 527 528 O
mg 26 28 528 530 O
/ 28 29 530 531 O
dL 29 31 531 533 O
) 31 32 533 534 O

Myelosuppressive 0 16 535 551 B-treatment
chemotherapy 17 29 552 564 I-treatment
: 29 30 564 565 O
At 31 33 566 568 O
least 34 39 569 574 O
21 40 42 575 577 B-lower_bound
days 43 47 578 582 I-lower_bound
must 48 52 583 587 O
have 53 57 588 592 O
elapsed 58 65 593 600 O
after 66 71 601 606 O
the 72 75 607 610 O
last 76 80 611 615 O
dose 81 85 616 620 O
of 86 88 621 623 O
myelosuppressive 89 105 624 640 B-treatment
chemotherapy 106 118 641 653 I-treatment

Patients 0 8 654 662 O
who 9 12 663 666 O
have 13 17 667 671 O
already 18 25 672 679 O
undergone 26 35 680 689 O
radiation 36 45 690 699 B-treatment
therapy 46 53 700 707 I-treatment
for 54 57 708 711 O
current 58 65 712 719 O
recurrence 66 76 720 730 O

Patients 0 8 731 739 O
with 9 13 740 744 O
evidence 14 22 745 753 O
of 23 25 754 756 O
metastatic 26 36 757 767 B-chronic_disease
spinal 37 43 768 774 I-chronic_disease
disease 44 51 775 782 I-chronic_disease
by 52 54 783 785 O
MRI 55 58 786 789 B-treatment

Peripheral 0 10 790 800 B-clinical_variable
absolute 11 19 801 809 I-clinical_variable
neutrophil 20 30 810 820 I-clinical_variable
count 31 36 821 826 I-clinical_variable
( 37 38 827 828 I-clinical_variable
ANC 38 41 828 831 I-clinical_variable
) 41 42 831 832 I-clinical_variable
≥1,000/µL 43 52 833 842 O

Pregnancy 0 9 843 852 B-pregnancy

Pregnancy 0 9 853 862 B-pregnancy
tests 10 15 863 868 O
must 16 20 869 873 O
be 21 23 874 876 O
obtained 24 32 877 885 O
in 33 35 886 888 O
females 36 43 889 896 B-gender
who 44 47 897 900 O
are 48 51 901 904 O
post 52 56 905 909 O
- 56 57 909 910 O
menarchal 57 66 910 919 O

Pregnant 0 8 920 928 B-pregnancy

Radiation 0 9 929 938 B-treatment
therapy 10 17 939 946 I-treatment
: 17 18 946 947 O
At 19 21 948 950 O
least 22 27 951 956 O
28 28 30 957 959 B-lower_bound
days 31 35 960 964 I-lower_bound
must 36 40 965 969 O
have 41 45 970 974 O
elapsed 46 53 975 982 O
( 54 55 983 984 O
at 55 57 984 986 O
time 58 62 987 991 O
of 63 65 992 994 O
starting 66 74 995 1003 O
protocol 75 83 1004 1012 O
therapy 84 91 1013 1020 O
) 91 92 1020 1021 O
since 93 98 1022 1027 O
completion 99 109 1028 1038 O
of 110 112 1039 1041 O
focal 113 118 1042 1047 B-treatment
radiation 119 128 1048 1057 I-treatment
therapy 129 136 1058 1065 I-treatment
for 137 140 1066 1069 O
current 141 148 1070 1077 O
recurrence 149 159 1078 1088 O
for 160 163 1089 1092 O
Stratum 164 171 1093 1100 O
2 172 173 1101 1102 O

Serum 0 5 1103 1108 B-clinical_variable
glutamic 6 14 1109 1117 I-clinical_variable
oxaloacetic 15 26 1118 1129 I-clinical_variable
transaminase 27 39 1130 1142 I-clinical_variable
( 40 41 1143 1144 I-clinical_variable
SGOT 41 45 1144 1148 I-clinical_variable
) 45 46 1148 1149 I-clinical_variable
( 47 48 1150 1151 I-clinical_variable
AST 48 51 1151 1154 I-clinical_variable
) 51 52 1154 1155 I-clinical_variable

Shortening 0 10 1156 1166 B-clinical_variable
fraction 11 19 1167 1175 I-clinical_variable
> 20 21 1176 1177 O
28 22 24 1178 1180 B-lower_bound
% 24 25 1180 1181 I-lower_bound
by 26 28 1182 1184 O
echocardiogram 29 43 1185 1199 O

Surgical 0 8 1200 1208 B-treatment
resection 9 18 1209 1218 I-treatment
: 18 19 1218 1219 O
Must 20 24 1220 1224 O
have 25 29 1225 1229 O
fully 30 35 1230 1235 O
healed 36 42 1236 1242 O
from 43 47 1243 1247 O
any 48 51 1248 1251 O
surgical 52 60 1252 1260 O
procedure 61 70 1261 1270 O
to 71 73 1271 1273 O
be 74 76 1274 1276 O
safe 77 81 1277 1281 O
for 82 85 1282 1285 O
lumbar 86 92 1286 1292 B-treatment
puncture 93 101 1293 1301 I-treatment
according 102 111 1302 1311 O
to 112 114 1312 1314 O
treating 115 123 1315 1323 O
neurosurgeon 124 136 1324 1336 O
and 137 140 1337 1340 O
at 141 143 1341 1343 O
least 144 149 1344 1349 O
14 150 152 1350 1352 B-lower_bound
days 153 157 1353 1357 I-lower_bound
should 158 164 1358 1364 O
have 165 169 1365 1369 O
elapsed 170 177 1370 1377 O
since 178 183 1378 1383 O
the 184 187 1384 1387 O
surgical 188 196 1388 1396 O
procedure 197 206 1397 1406 O

Total 0 5 1407 1412 B-clinical_variable
bilirubin 6 15 1413 1422 I-clinical_variable
≤1.5 16 20 1423 1427 O
x 21 22 1428 1429 I-upper_bound
upper 23 28 1430 1435 I-upper_bound
limit 29 34 1436 1441 I-upper_bound
of 35 37 1442 1444 I-upper_bound
normal 38 44 1445 1451 I-upper_bound
( 45 46 1452 1453 I-upper_bound
ULN 46 49 1453 1456 I-upper_bound
) 49 50 1456 1457 I-upper_bound
for 51 54 1458 1461 O
age 55 58 1462 1465 B-age

breast 0 6 1466 1472 O
- 6 7 1472 1473 O
feeding 7 14 1473 1480 O
women 15 20 1481 1486 B-gender

cardiac 0 7 1487 1494 B-chronic_disease
disease 8 15 1495 1502 I-chronic_disease
risk 16 20 1503 1507 O
factors 21 28 1508 1515 O

mixed 0 5 1516 1521 B-cancer
glioma 6 12 1522 1528 I-cancer

serum 0 5 1529 1534 B-clinical_variable
glutamate 6 15 1535 1544 I-clinical_variable
pyruvate 16 24 1545 1553 I-clinical_variable
transaminase 25 37 1554 1566 I-clinical_variable
( 38 39 1567 1568 I-clinical_variable
SGPT 39 43 1568 1572 I-clinical_variable
) 43 44 1572 1573 I-clinical_variable
( 45 46 1574 1575 I-clinical_variable
ALT 46 49 1575 1578 I-clinical_variable
) 49 50 1578 1579 I-clinical_variable
< 51 52 1580 1581 O
3 53 54 1582 1583 B-upper_bound
x 55 56 1584 1585 I-upper_bound
upper 57 62 1586 1591 I-upper_bound
limit 63 68 1592 1597 I-upper_bound
of 69 71 1598 1600 I-upper_bound
normal 72 78 1601 1607 I-upper_bound
( 79 80 1608 1609 I-upper_bound
ULN 80 83 1609 1612 I-upper_bound
) 83 84 1612 1613 I-upper_bound
for 85 88 1614 1617 O
age 89 92 1618 1621 B-age

significant 0 11 1622 1633 O
cardiac 12 19 1634 1641 B-chronic_disease
disease 20 27 1642 1649 I-chronic_disease

subependymoma 0 13 1650 1663 B-cancer

supratentorial 0 14 1664 1678 B-cancer
ependymoma 15 25 1679 1689 I-cancer

uncontrolled 0 12 1690 1702 O
arrhythmias 13 24 1703 1714 B-chronic_disease

who 0 3 1715 1718 O
are 4 7 1719 1722 O
currently 8 17 1723 1732 O
receiving 18 27 1733 1742 O
other 28 33 1743 1748 O
anti 34 38 1749 1753 B-treatment
- 38 39 1753 1754 I-treatment
cancer 39 45 1754 1760 I-treatment
agents 46 52 1761 1767 I-treatment

who 0 3 1768 1771 O
have 4 8 1772 1776 O
an 9 11 1777 1779 O
uncontrolled 12 24 1780 1792 O
serious 25 32 1793 1800 B-chronic_disease
infection 33 42 1801 1810 I-chronic_disease

who 0 3 1811 1814 O
have 4 8 1815 1819 O
been 9 13 1820 1824 O
treated 14 21 1825 1832 O
with 22 26 1833 1837 O
chemotherapy 27 39 1838 1850 B-treatment
at 40 42 1851 1853 O
time 43 47 1854 1858 O
of 48 50 1859 1861 O
recurrence 51 61 1862 1872 O

who 0 3 1873 1876 O
have 4 8 1877 1881 O
previously 9 19 1882 1892 O
received 20 28 1893 1901 O
solid 29 34 1902 1907 B-treatment
organ 35 40 1908 1913 I-treatment
transplantation 41 56 1914 1929 I-treatment

